On January 5, 2026, IGC Pharma, Inc. reported entering into a Subscription Agreement to sell 779,997 shares at $0.30 each, raising about $234,000 for corporate purposes and clinical development.
AI Assistant
IGC PHARMA INC
2026
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.